211 related articles for article (PubMed ID: 18815541)
21. Islet amyloid polypeptide inserts into phospholipid monolayers as monomer.
Engel MF; Yigittop H; Elgersma RC; Rijkers DT; Liskamp RM; de Kruijff B; Höppener JW; Antoinette Killian J
J Mol Biol; 2006 Feb; 356(3):783-9. PubMed ID: 16403520
[TBL] [Abstract][Full Text] [Related]
22. Islet amyloid and islet amyloid polypeptide in cynomolgus macaques (Macaca fascicularis): an animal model of human non-insulin-dependent diabetes mellitus.
O'Brien TD; Wagner JD; Litwak KN; Carlson CS; Cefalu WT; Jordan K; Johnson KH; Butler PC
Vet Pathol; 1996 Sep; 33(5):479-85. PubMed ID: 8885173
[TBL] [Abstract][Full Text] [Related]
23. "A" is for amylin and amyloid in type 2 diabetes mellitus.
Hayden MR; Tyagi SC
JOP; 2001 Jul; 2(4):124-39. PubMed ID: 11875249
[TBL] [Abstract][Full Text] [Related]
24. Distribution of pancreatic endocrine cells including IAPP-expressing cells in non-diabetic and type 2 diabetic cases.
Iki K; Pour PM
J Histochem Cytochem; 2007 Feb; 55(2):111-8. PubMed ID: 16982850
[TBL] [Abstract][Full Text] [Related]
25. Islet amyloid polypeptide in diabetic and non-diabetic Pima Indians.
Clark A; Saad MF; Nezzer T; Uren C; Knowler WC; Bennett PH; Turner RC
Diabetologia; 1990 May; 33(5):285-9. PubMed ID: 2198187
[TBL] [Abstract][Full Text] [Related]
26. Insular amyloidosis in spontaneously diabetic nonhuman primates.
Palotay JL; Howard CF
Vet Pathol Suppl; 1982 Sep; 19 Suppl 7():181-92. PubMed ID: 6153008
[TBL] [Abstract][Full Text] [Related]
27. Non-uniform distribution of islet amyloid in the pancreas of 'maturity-onset' diabetic patients.
Clark A; Holman RR; Matthews DR; Hockaday TD; Turner RC
Diabetologia; 1984 Nov; 27(5):527-8. PubMed ID: 6391995
[TBL] [Abstract][Full Text] [Related]
28. Heterogeneity in distribution of amyloid-positive islets in type-2 diabetic patients.
Borromeo CM; Pottier X; In't Veld PA; Pipeleers-Marichal MA; Kaufman L; Pipeleers DG; Van Schravendijk CF
Virchows Arch; 2005 Mar; 446(3):232-8. PubMed ID: 15791482
[TBL] [Abstract][Full Text] [Related]
29. Identification of the amyloid-degrading enzyme neprilysin in mouse islets and potential role in islet amyloidogenesis.
Zraika S; Hull RL; Udayasankar J; Clark A; Utzschneider KM; Tong J; Gerchman F; Kahn SE
Diabetes; 2007 Feb; 56(2):304-10. PubMed ID: 17259373
[TBL] [Abstract][Full Text] [Related]
30. Islet amyloid polypeptide and its N-terminal and C-terminal flanking peptides' immunoreactivity in islet amyloid of diabetic patients.
Kanatsuka A; Makino H; Yagui K; Huang CI; Taira M; Mikata A; Yoshida S
Diabetes Res Clin Pract; 1994 Dec; 26(2):101-7. PubMed ID: 7535678
[TBL] [Abstract][Full Text] [Related]
31. Amyloid formation by pro-islet amyloid polypeptide processing intermediates: examination of the role of protein heparan sulfate interactions and implications for islet amyloid formation in type 2 diabetes.
Meng F; Abedini A; Song B; Raleigh DP
Biochemistry; 2007 Oct; 46(43):12091-9. PubMed ID: 17924651
[TBL] [Abstract][Full Text] [Related]
32. Living alone is associated with an increased risk of type 2 diabetes mellitus in men but not women from the general population: the MONICA/KORA Augsburg Cohort Study.
Meisinger C; Kandler U; Ladwig KH
Psychosom Med; 2009 Sep; 71(7):784-8. PubMed ID: 19592514
[TBL] [Abstract][Full Text] [Related]
33. Feline insular amyloid: incidence in adult cats with no clinicopathologic evidence of overt diabetes mellitus.
Yano BL; Hayden DW; Johnson KH
Vet Pathol; 1981 May; 18(3):310-5. PubMed ID: 7020225
[TBL] [Abstract][Full Text] [Related]
34. [Amyloid of islets of Langerhans and its relation to diabetes mellitus (author's transl)].
Schneider HM; Störkel S; Will W
Dtsch Med Wochenschr; 1980 Aug; 105(33):1143-7. PubMed ID: 7004825
[TBL] [Abstract][Full Text] [Related]
35. Amyloidosis of the isletes of Langerhans in relation to diabetes mellitus and aging.
Melato M; Antonutto G; Ferronato E
Beitr Pathol; 1977 Apr; 160(1):73-81. PubMed ID: 324467
[TBL] [Abstract][Full Text] [Related]
36. Islet Amyloid in Patients With Diabetes Due to Exocrine Pancreatic Disorders, Type 2 Diabetes, and Nondiabetic Patients.
Ueberberg S; Nauck MA; Uhl W; Montemurro C; Tannapfel A; Clark A; Meier JJ
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32271378
[TBL] [Abstract][Full Text] [Related]
37. Effect of obesity on incidence of type 2 diabetes declines with age among Japanese women.
Fujita M; Ueno K; Hata A
Exp Biol Med (Maywood); 2009 Jul; 234(7):750-7. PubMed ID: 19429850
[TBL] [Abstract][Full Text] [Related]
38. [Amylin under examination. Fibrillogenic polypeptide hormone of the pancreas].
Marszałek M
Postepy Hig Med Dosw (Online); 2014 Jan; 68():29-41. PubMed ID: 24491893
[TBL] [Abstract][Full Text] [Related]
39. The influence of insulin on local amyloidosis of the islets of Langerhans and insulinoma.
Schneider HM; Störkel FS; Will W
Pathol Res Pract; 1980 Dec; 170(1-3):180-91. PubMed ID: 18788162
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of hypertension in patients with new onset type 2 diabetes mellitus.
Dhobi GN; Majid A; Masoodi SR; Bashir MI; Wani AI; Zargar AH
J Indian Med Assoc; 2008 Feb; 106(2):92, 94-8. PubMed ID: 18705251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
